Aumseqa
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Aumseqa, covering 2026-02-27 to 2026-02-27. Get the full timeline:
Most recent: EMA Authorised: Aumseqa (Aumolertinib mesilate) — SFL Pharmaceuticals Deutschland GmbH